Like_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":690373920,"tweetId":"690373920","gmtCreate":1639643555580,"gmtModify":1639643608491,"author":{"id":3575020360100013,"idStr":"3575020360100013","authorId":3575020360100013,"authorIdStr":"3575020360100013","name":"5c314778","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":28,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like</p></body></html>","htmlText":"<html><head></head><body><p>Like</p></body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/690373920","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","kind":"news","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RLFTY":"RELIEF THERAPEUTICS HLDG AG"},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1180,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/690373920"}